Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.53−0.71 (-6.93%)
Close on Nov 13, 2026Market cap $554.07MP/E –Yield –
Capricor Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Capricor Therapeutics's enterprise value was $414.05M on Nov 11, 2026, against $145.99M a year earlier. Over the last 5 years it ranged from -$56.60M to $1.61B, with a median of $124.65M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $414.05M | -66.1% |
| 2025 | Dec 31, 2025 | $1.22B | +158.9% |
| 2024 | Dec 31, 2024 | $471.59M | +381.5% |
| 2023 | Dec 29, 2023 | $97.93M | +100.9% |
| 2022 | Dec 30, 2022 | $48.75M | +63.0% |
| 2021 | Dec 31, 2021 | $29.92M | -12.4% |
| 2020 | Dec 31, 2020 | $34.15M | – |
| 2019 | Dec 31, 2019 | -$1.48M | -166.4% |
| 2018 | Dec 31, 2018 | $2.24M | -92.6% |
| 2017 | Dec 29, 2017 | $30.15M | -21.3% |
| 2016 | Dec 30, 2016 | $38.30M | +17.2% |
| 2015 | Dec 31, 2015 | $32.68M | -3.2% |
| 2014 | Dec 31, 2014 | $33.76M | +2.3% |
| 2013 | Dec 31, 2013 | $33.00M | +31.8% |
| 2012 | Dec 31, 2012 | $25.05M | -90.2% |
| 2011 | Dec 30, 2011 | $254.33M | – |
See a number that looks wrong?